APEH and cancer: Therefore, this study shows that proteasome functions can be upstream regulated by APEH, and that inhibition of APEH activity appears to be an important event in controlling the proteasome dysfunction associated with pathological conditions, opening new important and challenging perspectives for the development of novel strategies in cancer therapy.